Pharmacogenetic diversification by alternative translation initiation: background channels to the fore: Commentary on Kisselbach et al., Br J Pharmacol 171: 5182-5194

This article is a Commentary on Kisselbach J, Seyler C, Schweizer PA, Gerstberger R, Becker R, Katus HA and Thomas D (2014). Modulation of K2P2.1 and K2P10.1 K+ channel sensitivity to carvedilol by alternative mRNA translation initiation. Br J Pharmacol 171: 5182-5194. doi: 10.1111/bph.12596.